Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-26-255521
Filing Date
2026-06-03
Accepted
2026-06-03 16:24:25
Documents
7
Effectiveness Date
2026-06-03

Document Format Files

Seq Description Document Type Size
1 S-8 POS xene-2026-s-8_pos_14_pla.htm S-8 POS 367797
2 EX-5.1 xene-ex5_1.htm EX-5.1 17569
3 EX-23.1 xene-ex23_1.htm EX-23.1 3999
4 EX-23.2 xene-ex23_2.htm EX-23.2 6144
5 GRAPHIC img3998686_0.gif GRAPHIC 12424
6 GRAPHIC img3998686_1.gif GRAPHIC 10624
7 GRAPHIC img3998686_2.gif GRAPHIC 4839
  Complete submission text file 0001193125-26-255521.txt   435452
Mailing Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada
Business Address 200 - 3650 GILMORE WAY BURNABY British Columbia, Canada (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-238895 | Film No.: 261061003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)